Scott Wasserman

Scott Wasserman

No open positions remaining

Net worth: - $ as of 30/05/2026

56 year
Consumer Services
Health Technology
Finance

Profile

Scott M.
Wasserman
is Chief Medical Officer at Kailera Therapeutics, Inc. since 2024.
Former roles include Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023, Vice President & Global Development at Amgen, Inc. from 2015 to 2019, and Venture Partner at Frazier Management LLC from 2023 to 2024.
Education includes an undergraduate degree from Haverford College in 1992, a doctorate from Harvard Medical School in 1997, and an undergraduate degree from Stanford University School of Medicine in 2004.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
15/04/2026 0 ( -.--% ) - $ 30/05/2026

Scott Wasserman active positions

CompaniesPositionStart

Former positions of Scott Wasserman

CompaniesPositionEnd
Private Equity Investor 30/09/2024
Chief Executive Officer 31/05/2023
AMGEN INC. Private Equity Investor 30/04/2019
See the detail of Scott Wasserman's experience

Training of Scott Wasserman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

88

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Scott Wasserman